Slack named permanent director of CDER’s strategic programs

FDA’s Center for Drug Evaluation and Research appointed Mary Ann Slack permanent director of its Office of Strategic Programs, which oversees data standardization, program analysis, business informatics, user fee negotiations and the development of benefit-risk decision support tools. Slack had served as acting OSP director since March 2018, before which she was OSP deputy director. ...